Insulet to Present at Upcoming Investor Conferences

Rhea-AI Summary

Insulet Corporation (NASDAQ: PODD) will present at three virtual investor conferences: the Wells Fargo Healthcare Conference on September 9, the Morgan Stanley Global Healthcare Conference on September 10, and the Baird Global Healthcare Conference on September 15, 2021. Each presentation will be accessible via live webcasts, which will also have replays available afterwards. Insulet specializes in innovative diabetes management technology, specifically its Omnipod tubeless insulin delivery system, designed to simplify life for individuals with diabetes.

ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod^® brand of products, today announced that management will present at three upcoming virtual investor conferences:

• The 2021 Virtual Wells Fargo Healthcare Conference on Thursday, September 9, 2021 at 1:20 p.m. (Eastern Time)
• The Morgan Stanley 19th Annual Global Healthcare Conference on Friday, September 10, 2021 at 1:15 p.m. (Eastern Time)
• The Baird 2021 Global Healthcare Conference on Wednesday, September 15, 2021 at 2:00 p.m. (Eastern Time)

To listen to the live webcasts of the presentations, please visit investors.insulet.com/events. Replays of the webcasts will also be available following the event.

About Insulet Corporation:

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit: insulet.com and omnipod.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210826005572/en/

Investor Relations:



Deborah R. Gordon

Vice President, Investor Relations

(978) 600-7717

dgordon@insulet.com



Media:



Angela Geryak Wiczek

Senior Director, Corporate Communications

(978) 932-0611

awiczek@insulet.com

Source: Insulet Corporation

FAQ

What is the schedule for Insulet's presentations at investor conferences?

Insulet Corporation will present at three virtual investor conferences: Wells Fargo Healthcare Conference on September 9, 2021, at 1:20 p.m. ET, Morgan Stanley Global Healthcare Conference on September 10, 2021, at 1:15 p.m. ET, and Baird Global Healthcare Conference on September 15, 2021, at 2:00 p.m. ET.

Where can I watch the live webcasts of Insulet's investor presentations?

The live webcasts of Insulet Corporation's presentations can be watched at investors.insulet.com/events.

What technology does Insulet Corporation specialize in?

Insulet Corporation specializes in tubeless insulin pump technology, particularly through its Omnipod product platform, aimed at simplifying diabetes management.

What is the main benefit of Insulet's Omnipod system?

The Omnipod Insulin Management System offers a unique, needle-free alternative for continuous insulin delivery, enhancing convenience for users.